An abbreviated version of CDDEP's weekly digest of public health news, focusing on antibiotic resistance research in the United States.
The Centers for Disease Control and Prevention (CDC) releases a Vital Signs report on U.S. trends in infections with Clostridium difficile, a gastrointestinal bug linked with taking antibiotics and receiving medical care. C. diff hospitalizations have risen threefold in the past decade, and deaths increased by 400% between 2000 and 2007.
The Center for Science in the Public Interest releases a white paper detailing antibiotic resistant foodborne illnesses in 2011 across the United States.
To address a dwindling antibiotic pipeline, the Infectious Diseases Society of America is urging the FDA to treat certain new antibiotics as “orphan drugs.” The Orphan Drug Act passed in 1983 provides incentives for pharmaceutical companies to invest in medicines for rare diseases.
Medscape profiles bacteriophages, viruses capable of invading bacteria and interrupting replication. Could these viruses treat bacterial infections and evade antibiotic resistance?
A new book from the World Health Organization's follows on the theme of World Health Day 2011: antimicrobial resistance (AMR). "The evolving threat of antimicrobial resistance – options for action" describes policy activities that have addressed antimicrobial resistance in different parts of the world as well as some of the progress made since the publication of the WHO's 2001 AMR strategy.
You can sign up to receive the full weekly digest via email on the CDDEP website.
Image credit: Flickr: wallyg